ChronoScale Holdings announced a significant expansion with an existing AI infrastructure customer and a new agreement with another, which are expected to drive the company's annualized revenue run-rate to $1 billion. Concurrently, the company completed the sale of its Ekso Bionics business unit to sharpen its focus on its core accelerated compute and AI infrastructure business.
Key Details
- Revenue Projection: New and existing customer agreements are expected to achieve an annualized run-rate revenue of $1 billion by calendar Q3 2027.
- Strategic Divestiture: The company completed the sale of its wholly-owned subsidiary, Ekso Bionics, Inc., on September 30, 2026, to concentrate resources on its AI operations.
- Management Change: In connection with the sale, Ekso Bionics' COO, Jason C. Jones, was terminated and will receive a lump-sum severance payment of $243,750.